Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Flutamide-induced methemoglobinemia.

A M Schott1, T Vial, I Gozzo

  • 1Department of Rheumatology, E. Herriot Hospital, Lyon, France.

DICP : the Annals of Pharmacotherapy
|June 1, 1991
PubMed
Summary

Flutamide, a medication for prostate cancer, can cause methemoglobinemia, a condition where hemoglobin cannot carry oxygen effectively. This case highlights the importance of considering drug-induced methemoglobinemia in patients with cyanosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are there socio-economic inequities in access to reperfusion therapy: The stroke 69 cohort.

Revue neurologique·2021
Same author

[Algorithms to identify chronic inflammatory rheumatism and psoriasis in medico-administrative databases: A review of the literature].

Revue d'epidemiologie et de sante publique·2021
Same author

[Contribution of a hospital pharmacy team to critical care of patients infected with SARS-CoV-2].

Annales pharmaceutiques francaises·2021
Same author

Short and long-term impact of four sets of actions on acute ischemic stroke management in Rhône County, a population based before-and-after prospective study.

BMC health services research·2021
Same author

Osteoporosis prevention: where are the barriers to improvement in a French general population? A qualitative study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018
Same author

Association of hypovitaminosis D with triceps brachii muscle fatigability among older women: Findings from the EPIDOS cohort.

Maturitas·2018

Area of Science:

  • Pharmacology
  • Oncology
  • Hematology

Background:

  • Flutamide is an anti-androgen medication commonly used for prostate cancer treatment.
  • Prostate cancer with bone metastasis often requires long-term therapeutic interventions.

Observation:

  • A patient on flutamide developed severe cyanosis and dyspnea.
  • Laboratory results indicated 16.2% methemoglobinemia without other identifiable causes.
  • Congenital methemoglobinemia and other exposures were ruled out.

Findings:

  • Discontinuation of flutamide led to clinical improvement and normalization of methemoglobin levels.
  • The patient's condition strongly suggests flutamide-induced methemoglobinemia.
  • Flutamide's anilide-derived chemical structure points to its potential as a methemoglobin-inducing agent.

Related Experiment Videos

Implications:

  • Clinicians should consider flutamide as a potential cause of acquired methemoglobinemia in patients presenting with cyanosis.
  • This case underscores the need for vigilant monitoring of potential adverse drug reactions in oncology patients.
  • Further research into the mechanism of flutamide-induced methemoglobinemia is warranted.